Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2010 2
2011 4
2012 2
2014 4
2015 4
2016 4
2017 2
2018 3
2019 4
2020 3
2021 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Recent advances in the development of breast cancer vaccines.
Milani A, Sangiolo D, Aglietta M, Valabrega G. Milani A, et al. Breast Cancer (Dove Med Press). 2014 Oct 14;6:159-68. doi: 10.2147/BCTT.S38428. eCollection 2014. Breast Cancer (Dove Med Press). 2014. PMID: 25339848 Free PMC article. Review.
Clinical utility of exemestane in the treatment of breast cancer.
Zucchini G, Geuna E, Milani A, Aversa C, Martinello R, Montemurro F. Zucchini G, et al. Among authors: milani a. Int J Womens Health. 2015 May 27;7:551-63. doi: 10.2147/IJWH.S69475. eCollection 2015. Int J Womens Health. 2015. PMID: 26064072 Free PMC article. Review.
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
Cazzaniga ME, Biganzoli L, Cortesi L, De Placido S, Donadio M, Fabi A, Ferro A, Generali D, Lorusso V, Milani A, Montagna E, Munzone E, Orlando L, Pizzuti L, Simoncini E, Zamagni C, Pappagallo GL; “Metronomic Chemotherapy in Advanced Breast Cancer” Study Group. Cazzaniga ME, et al. Among authors: milani a. Onco Targets Ther. 2019 Apr 23;12:2989-2997. doi: 10.2147/OTT.S189163. eCollection 2019. Onco Targets Ther. 2019. PMID: 31114242 Free PMC article.
Buparlisib , an oral pan-PI3K inhibitor for the treatment of breast cancer.
Geuna E, Milani A, Martinello R, Aversa C, Valabrega G, Scaltriti M, Montemurro F. Geuna E, et al. Among authors: milani a. Expert Opin Investig Drugs. 2015 Mar;24(3):421-31. doi: 10.1517/13543784.2015.1008132. Epub 2015 Feb 3. Expert Opin Investig Drugs. 2015. PMID: 25645727 Review.
Linifanib: current status and future potential in cancer therapy.
Aversa C, Leone F, Zucchini G, Serini G, Geuna E, Milani A, Valdembri D, Martinello R, Montemurro F. Aversa C, et al. Among authors: milani a. Expert Rev Anticancer Ther. 2015 Jun;15(6):677-87. doi: 10.1586/14737140.2015.1042369. Epub 2015 May 2. Expert Rev Anticancer Ther. 2015. PMID: 25936222 Review.
39 results